PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Chemical Biology and Bioimaging, Wroclaw University of Science and Technology, Wroclaw, Poland. wioletta.rut@pwr.edu.pl.\', \'Department of Chemical Biology and Bioimaging, Wroclaw University of Science and Technology, Wroclaw, Poland.\', \'Institute of Molecular Medicine, University of Lübeck, Lübeck, Germany.\', \'Institute of Biochemistry, Center for Structural and Cell Biology in Medicine, University of Lübeck, Lübeck, Germany.\', \'German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems Site, University of Lübeck, Lübeck, Germany.\', \'Department of Pediatrics, Oncology & Hematology, Medical University of Lodz, Lodz, Poland.\', \'Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.\', \'Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.\', \'Center for Brain, Behavior, and Metabolism, University of Lübeck, Lübeck, Germany.\', \'Department of Chemical Biology and Bioimaging, Wroclaw University of Science and Technology, Wroclaw, Poland. marcin.drag@pwr.edu.pl.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41589-020-00689-z
?:doi
?:hasPublicationType
?:journal
  • Nature chemical biology
is ?:pmid of
?:pmid
?:pmid
  • 33093684
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 8.604
?:rankingScore_hIndex
  • 173
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all